Drug that causes patients to bleed to death was approved under questionable circumstances by Obama FDA nominee

“(NaturalNews) Meet Robert Califf. He was recently appointed as Deputy Commissioner for Medical Products and Tobacco at the FDA, by the Obama administration. This is the same guy who worked at the Duke Institute for Clinical Research, where he co-chaired the executive committee for the clinical trials of the pharmaceutical blood-thinning drug, Xarelto.”
Read the whole article here!



Go back to: Healthy Being – Discovering a healthy common sense

Comments are closed.